Shattuck Labs (STTK) Stock Forecast & Price Target

Compare

243 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

STTK Analyst Ratings

Strong Buy

5 Buy

1 Hold

0 Sell

Based on 6 analysts giving stock ratings to

Shattuck

Labs

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

STTK Stock 12 Month Forecast

Average Price Target

$10.00

▲(60.77% Upside)

Based on 6 Wall Street analysts offering 12 month price targets for Shattuck Labs in the last 3 months. The average price target is $10.00 with a high forecast of $15.00 and a low forecast of $6.00. The average price target represents a 60.77% change from the last price of $6.22.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"16":"$16","-1":"-$1","3.25":"$3.25","7.5":"$7.5","11.75":"$11.75"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":15,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$15.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":10,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$10.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":6,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$6.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[-1,3.25,7.5,11.75,16],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"May<br/>2025","6":"Aug<br/>2025","9":"Nov<br/>2025","12":"Mar<br/>2026","25":"Mar<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,4,4.846153846153846,5.6923076923076925,6.538461538461538,7.384615384615385,8.23076923076923,9.076923076923077,9.923076923076923,10.76923076923077,11.615384615384615,12.461538461538462,13.307692307692308,14.153846153846153,{"y":15,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,4,4.461538461538462,4.923076923076923,5.384615384615385,5.846153846153847,6.307692307692308,6.769230769230769,7.230769230769231,7.6923076923076925,8.153846153846153,8.615384615384617,9.076923076923077,9.538461538461538,{"y":10,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,4,4.153846153846154,4.3076923076923075,4.461538461538462,4.615384615384615,4.769230769230769,4.923076923076923,5.076923076923077,5.230769230769231,5.384615384615385,5.538461538461538,5.6923076923076925,5.846153846153847,{"y":6,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":1.16,"date":1738368000000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":1.32,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.84,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.08,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.04,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.82,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.73,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 23, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.01,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 22, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.38,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 30, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.92,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 16, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.41,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 25, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.65,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 27, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 31, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$15.00

Average Price Target$10.00

Lowest Price Target$6.00

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Yigal Nochomovitz

Citi

$4→$7

Hold

12.54%

Upside

Reiterated

03/12/26

Analysts Have Conflicting Sentiments on These Healthcare Companies: Shattuck Labs (NASDAQ: STTK), Oruka Therapeutics (NASDAQ: ORKA) and Option Care Health (NASDAQ: OPCH)

Joseph Stringer

Needham

$14

Buy

125.08%

Upside

Initiated

03/06/26

Buy Rating on SL-325: Differentiated DR3 Targeting in IBD Supports Attractive Risk/Reward and $14 Price Target

Marc Frahm

TD Cowen

―

Buy

―

Reiterated

03/06/26

Analysts Offer Insights on Healthcare Companies: TriSalus Life Sciences (NASDAQ: TLSI) and Shattuck Labs (NASDAQ: STTK)

David Nierengarten

Wedbush

$4→$8

Buy

28.62%

Upside

Reiterated

03/06/26

Shattuck Labs price target raised to $8 from $4 at WedbushShattuck Labs price target raised to $8 from $4 at Wedbush

Joseph Pantginis

H.C. Wainwright

Buy

-3.54%

Downside

Reiterated

03/05/26

Analysts Offer Insights on Healthcare Companies: Lifecore Biomedical (NASDAQ: LFCR), Compass Therapeutics (NASDAQ: CMPX) and Shattuck Labs (NASDAQ: STTK)

Yasmeen Rahimi

Piper Sandler

$15

Buy

141.16%

Upside

Initiated

01/28/26

Shattuck Labs initiated with an Overweight at Piper SandlerShattuck Labs initiated with an Overweight at Piper Sandler

Faisal Khurshid

Jefferies

$4→$2

Buy

-67.85%

Downside

Reiterated

08/18/25

Shattuck Labs price target lowered to $2 from $4 at LeerinkShattuck Labs price target lowered to $2 from $4 at Leerink

Analyst Type

Any

Human Analysts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Yigal Nochomovitz

Citi

$4→$7

Hold

12.54%

Upside

Reiterated

03/12/26

Analysts Have Conflicting Sentiments on These Healthcare Companies: Shattuck Labs (NASDAQ: STTK), Oruka Therapeutics (NASDAQ: ORKA) and Option Care Health (NASDAQ: OPCH)

Joseph Stringer

Needham

$14

Buy

125.08%

Upside

Initiated

03/06/26

Buy Rating on SL-325: Differentiated DR3 Targeting in IBD Supports Attractive Risk/Reward and $14 Price Target

Marc Frahm

TD Cowen

―

Buy

―

Reiterated

03/06/26

Analysts Offer Insights on Healthcare Companies: TriSalus Life Sciences (NASDAQ: TLSI) and Shattuck Labs (NASDAQ: STTK)

David Nierengarten

Wedbush

$4→$8

Buy

28.62%

Upside

Reiterated

03/06/26

Shattuck Labs price target raised to $8 from $4 at WedbushShattuck Labs price target raised to $8 from $4 at Wedbush

Joseph Pantginis

H.C. Wainwright

Buy

-3.54%

Downside

Reiterated

03/05/26

Analysts Offer Insights on Healthcare Companies: Lifecore Biomedical (NASDAQ: LFCR), Compass Therapeutics (NASDAQ: CMPX) and Shattuck Labs (NASDAQ: STTK)

Yasmeen Rahimi

Piper Sandler

$15

Buy

141.16%

Upside

Initiated

01/28/26

Shattuck Labs initiated with an Overweight at Piper SandlerShattuck Labs initiated with an Overweight at Piper Sandler

Faisal Khurshid

Jefferies

$4→$2

Buy

-67.85%

Downside

Reiterated

08/18/25

Shattuck Labs price target lowered to $2 from $4 at LeerinkShattuck Labs price target lowered to $2 from $4 at Leerink

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Shattuck Labs

3 Months

xxx

Success Rate

5/12 ratings generated profit

Average Return

+37.23%

reiterated a xxx

rating 17 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 41.67% of your transactions generating a profit, with an average return of +37.23% per trade.

1 Year

Marc FrahmTD Cowen

Success Rate

6/12 ratings generated profit

Average Return

+119.61%

reiterated a buy rating 17 days ago

Copying Marc Frahm's trades and holding each position for 1 Year would result in 50.00% of your transactions generating a profit, with an average return of +119.61% per trade.

2 Years

xxx

Success Rate

8/12 ratings generated profit

Average Return

+181.02%

reiterated a xxx

rating 17 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 66.67% of your transactions generating a profit, with an average return of +181.02% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

STTK Analyst Recommendation Trends

Rating

Oct 25

Nov 25

Dec 25

Jan 26

Mar 26

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, STTK has received 6 Buy Ratings, 31 Hold Ratings, and 0 Sell Ratings. STTK average Analyst price target in the past 3 months is 10.00.

Each month's total comprises the sum of three months' worth of ratings.

STTK Financial Forecast

STTK Earnings Forecast

Next quarter’s earnings estimate for STTK is -$0.14 with a range of -$0.19 to -$0.12. The previous quarter’s EPS was -$0.12. STTK beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.43% of the time in the same period. In the last calendar year STTK has Performed in-line its overall industry.

STTK Sales Forecast

Next quarter’s sales forecast for STTK is $0.00 with a range of $0.00 to $0.00. The previous quarter’s sales results were $0.00. STTK beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 49.17% of the time in the same period. In the last calendar year STTK has Performed in-line its overall industry.

STTK Stock Forecast FAQ

What is STTK’s average 12-month price target, according to analysts?

Based on analyst ratings, Shattuck Labs’s 12-month average price target is 10.00.

What is STTK’s upside potential, based on the analysts’ average price target?

Shattuck Labs has 60.77% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is STTK a Buy, Sell or Hold?

Shattuck Labs has a consensus rating of Strong Buy which is based on 5 buy ratings, 1 hold ratings and 0 sell ratings.

What is Shattuck Labs’s price target?

The average price target for Shattuck Labs is 10.00. This is based on 6 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $15.00 ,the lowest forecast is $6.00. The average price target represents 60.77% Increase from the current price of $6.22.

What do analysts say about Shattuck Labs?

Shattuck Labs’s analyst rating consensus is a Strong Buy. This is based on the ratings of 6 Wall Streets Analysts.

How can I buy shares of STTK?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

Shattuck Labs (STTK) Stock Forecast & Price Target

STTK Analyst Ratings

STTK Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Shattuck Labs

STTK Analyst Recommendation Trends

STTK Financial Forecast

STTK Earnings Forecast

STTK Sales Forecast

STTK Stock Forecast FAQ

Detailed List of Analyst Forecasts